J S Kelloway

765 total citations
16 papers, 581 citations indexed

About

J S Kelloway is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Physiology. According to data from OpenAlex, J S Kelloway has authored 16 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Physiology. Recurrent topics in J S Kelloway's work include Asthma and respiratory diseases (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). J S Kelloway is often cited by papers focused on Asthma and respiratory diseases (5 papers), Inhalation and Respiratory Drug Delivery (4 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). J S Kelloway collaborates with scholars based in United States. J S Kelloway's co-authors include Richard A. Wyatt, Carl S. Hornfeldt, Susan Adlis, Charles E. Halstenson, C E Halstenson, Stephen W. Zimmerman, Alfred Tonelli, John M. Haynes, Robert Faulkner and Curtis A. Johnson and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Antimicrobial Agents and Chemotherapy and Clinical Pharmacology & Therapeutics.

In The Last Decade

J S Kelloway

14 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J S Kelloway United States	10	321	273	114	109	62	16	581
Elaine Nguyen United States	16	287 0.9×	235 0.9×	67 0.6×	31 0.3×	63 1.0×	67	922
Matthew Dahl Canada	14	88 0.3×	63 0.2×	63 0.6×	46 0.4×	6 0.1×	26	649
Hamid Tavakoli Canada	17	334 1.0×	283 1.0×	43 0.4×	19 0.2×	20 0.3×	54	669
Emma J Welsh United Kingdom	10	315 1.0×	328 1.2×	23 0.2×	38 0.3×	4 0.1×	16	629
Allan Ellsworth United States	12	55 0.2×	60 0.2×	30 0.3×	35 0.3×	47 0.8×	26	703
Andrea Hämmerlein Germany	7	83 0.3×	113 0.4×	89 0.8×	14 0.1×	59 1.0×	8	403
Daniel J. Sklansky United States	12	249 0.8×	102 0.4×	84 0.7×	25 0.2×	25 0.4×	35	702
S Nakazawa Japan	8	96 0.3×	32 0.1×	42 0.4×	36 0.3×	2 0.0×	38	460
Bradley R. Williams United States	14	78 0.2×	17 0.1×	98 0.9×	101 0.9×	51 0.8×	34	722
Eric Schirm Netherlands	15	63 0.2×	63 0.2×	529 4.6×	55 0.5×	20 0.3×	21	854

Countries citing papers authored by J S Kelloway

Since Specialization

Citations

This map shows the geographic impact of J S Kelloway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J S Kelloway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J S Kelloway more than expected).

Fields of papers citing papers by J S Kelloway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J S Kelloway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J S Kelloway. The network helps show where J S Kelloway may publish in the future.

Co-authorship network of co-authors of J S Kelloway

This figure shows the co-authorship network connecting the top 25 collaborators of J S Kelloway. A scholar is included among the top collaborators of J S Kelloway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J S Kelloway. J S Kelloway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Kelloway, J S, Joshua N. Liberman, Jonathan Darer, et al.. (2025). Real-World Evaluation of an EHR-Enabled Chronic Obstructive Pulmonary Disease Assessment Test. International Journal of COPD. Volume 20. 325–334.

Chavez, Mary L., Eric W. Jackson, Steven L. Barriere, et al.. (2008). Pharmacists and Industry: Guidelines for Ethical Interactions. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(3). 410–420. 9 indexed citations

Hornfeldt, Carl S., et al.. (2004). The Xyrem?? Risk Management Program. Drug Safety. 27(5). 293–306. 49 indexed citations

Kelloway, J S, et al.. (2002). Does using a mouthwash instead of water improve the oropharyngeal removal of inhaled flovent (fluticasone propionate)?. PubMed. 22(6). 367–71. 7 indexed citations

Kelloway, J S, et al.. (2000). Effect of salmeterol on patients' adherence to their prescribed refills for inhaled corticosteroids. Annals of Allergy Asthma & Immunology. 84(3). 324–328. 22 indexed citations

Kelloway, J S. (1997). Zafirlukast: The First Leukotreene-Receptor Antagonist Approved for the Treatment of Asthma. Annals of Pharmacotherapy. 31(9). 1012–1021. 41 indexed citations

Kelloway, J S & Richard A. Wyatt. (1997). A cost-effectiveness analysis of breath-actuated metered-dose inhalers.. PubMed. 10(9). 99–107. 10 indexed citations

Schoenwetter, William F., et al.. (1996). 296 General health status in rhinitis and asthma patients. Journal of Allergy and Clinical Immunology. 97(1). 256–256.

Kelloway, J S. (1994). Comparison of Patients' Compliance With Prescribed Oral and Inhaled Asthma Medications. Archives of Internal Medicine. 154(12). 1349–1349. 261 indexed citations

10.

Kelloway, J S. (1994). Comparison of patients' compliance with prescribed oral and inhaled asthma medications. Archives of Internal Medicine. 154(12). 1349–1352. 72 indexed citations

11.

Kelloway, J S, et al.. (1993). Evaluation of the Autohaler Actuator: The Effect of Written Patient Instructions on Correct Use. Journal of Asthma. 30(5). 373–379. 9 indexed citations

12.

Johnson, Curtis A., Charles E. Halstenson, J S Kelloway, et al.. (1992). Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease. Clinical Pharmacology & Therapeutics. 51(1). 32–41. 55 indexed citations

13.

Borin, Marie T., et al.. (1992). Disposition of Cefpodoxime Proxetil in Hemodialysis Patients. The Journal of Clinical Pharmacology. 32(11). 1038–1044. 6 indexed citations

14.

Peter, John V. St., et al.. (1992). Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function. Antimicrobial Agents and Chemotherapy. 36(1). 126–131. 11 indexed citations

15.

Kelloway, J S, Walid M. Awni, Cheng‐Chieh Lin, et al.. (1991). Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency. Antimicrobial Agents and Chemotherapy. 35(11). 2267–2274. 19 indexed citations

16.

Halstenson, C E, et al.. (1991). Isepamicin disposition in subjects with various degrees of renal function. Antimicrobial Agents and Chemotherapy. 35(11). 2382–2387. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact